KEVIN BOONE: Open Payments
NPI 1376869669 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 81 payments from 32 companies in 2025. Trend: 2023 $1,771 · 2024 $1,604 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $261 |
| UCB, Inc. | 6 | $129 |
| Amgen Inc. | 5 | $97 |
| Kerecis Limited | 3 | $70 |
| Lilly USA, LLC | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Indivior Inc. | 3 | $65 |
| ARGENX US, INC. | 4 | $62 |
| HARMONY BIOSCIENCES LLC | 2 | $56 |
| Smith+Nephew, Inc. | 2 | $52 |
Products named: Briviact, Kerecis SurgiClose, AUSTEDO XR, SUBLOCADE, WAKIX, ENBREL, UBRELVY, QULIPTA.
Industry payments across IN — which companies pay providers there.
